Neurotoxicity of MDMA: Main effects and mechanisms.
Study Goal
The researchers aimed to review preclinical and clinical findings on MDMA's central effects and mechanisms of neurotoxicity.
Results Summary
The study indicates MDMA has abuse potential and may cause acute and persistent central abnormalities, including neurotoxic effects observed in animals, posing serious health risks for recreational users.
Population
Preclinical (animal) and clinical (human) studies, focusing on young and adult recreational users.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') | increase | acute and persistent abnormalities of varying severity at the central level | - | - | may elicit | #1 |
MDMA | increase | neurotoxic effects | experimental animals | - | have been demonstrated | #2 |
MDMA | increase | a serious harm for health | young and adult people | - | may pose | #3 |
Preclinical and clinical studies indicate that 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'), in addition to having abuse potential, may elicit acute and persistent abnormalities of varying severity at the central level. Importantly, neurotoxic effects of MDMA have been demonstrated in experimental animals. Accordingly, central toxicity induced by MDMA may pose a serious harm for health, since MDMA is among the substances that are used for recreational purposes by young and adult people. This review provides a concise overview of recent findings from preclinical and clinical studies that evaluated the central effects of MDMA, and the mechanisms involved in the neurotoxicity induced by this amphetamine-related drug.